Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
暂无分享,去创建一个
D. Hayes | H. Lenz | E. Vokes | A. Argiris | A. Razak | J. Gilbert | T. Karrison | F. Worden | E. Cohen | N. Saba | M. Kies | N. Takebe | K. Cullen | T. Tanvetyanon | D. Lim | J. Roberts | S. Wong